Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses. 2009

Kengo Saito, and Hiroshi Shirasawa, and Naohisa Isegawa, and Masashi Shiiba, and Katsuhiro Uzawa, and Hideki Tanzawa
Department of Molecular Virology (E2), Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.

Oncolytic virotherapy utilizes viruses that can selectively destroy cancer cells without harming normal tissues. Clinical trials of oncolytic viruses show that most oncolytic agents are well tolerated and safe. The virotherapeutic agents currently in use have limited potency when administered alone; however, combination therapy using virotherapeutic agents and conventional anticancer agents, such as chemotherapeutics, radiation, and gene therapy, exhibits encouraging levels of efficacy. Advances in recombinant DNA technology have allowed the development of viruses that are tumor-selective and armed with transgenes, increasing the application potential and efficacy of this novel anticancer therapy. Here, we review the development of oncolytic viruses and the clinical trials of oncolytic virotherapy for oral cancers. We discuss current issues and perspectives of this evolving anticancer therapy, highlighting the potential applications of a unique, naturally occurring oncolytic virus, Sindbis virus.

UI MeSH Term Description Entries
D009062 Mouth Neoplasms Tumors or cancer of the MOUTH. Cancer of Mouth,Mouth Cancer,Oral Cancer,Oral Neoplasms,Cancer of the Mouth,Neoplasms, Mouth,Neoplasms, Oral,Cancer, Mouth,Cancer, Oral,Cancers, Mouth,Cancers, Oral,Mouth Cancers,Mouth Neoplasm,Neoplasm, Mouth,Neoplasm, Oral,Oral Cancers,Oral Neoplasm
D009522 Newcastle disease virus The most well known avian paramyxovirus in the genus AVULAVIRUS and the cause of a highly infectious pneumoencephalitis in fowl. It is also reported to cause CONJUNCTIVITIS in humans. Transmission is by droplet inhalation or ingestion of contaminated water or food. Avian Paramyxovirus 1,Paramyxovirus 1, Avian
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D012845 Sindbis Virus The type species of ALPHAVIRUS normally transmitted to birds by CULEX mosquitoes in Egypt, South Africa, India, Malaya, the Philippines, and Australia. It may be associated with fever in humans. Serotypes (differing by less than 17% in nucleotide sequence) include Babanki, Kyzylagach, and Ockelbo viruses. Babanki virus,Kyzylagach virus,Ockelbo Virus
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

Kengo Saito, and Hiroshi Shirasawa, and Naohisa Isegawa, and Masashi Shiiba, and Katsuhiro Uzawa, and Hideki Tanzawa
June 2007, Uirusu,
Kengo Saito, and Hiroshi Shirasawa, and Naohisa Isegawa, and Masashi Shiiba, and Katsuhiro Uzawa, and Hideki Tanzawa
January 2008, Anticancer research,
Kengo Saito, and Hiroshi Shirasawa, and Naohisa Isegawa, and Masashi Shiiba, and Katsuhiro Uzawa, and Hideki Tanzawa
January 2005, Neurosurgery,
Kengo Saito, and Hiroshi Shirasawa, and Naohisa Isegawa, and Masashi Shiiba, and Katsuhiro Uzawa, and Hideki Tanzawa
April 2008, Biochimica et biophysica acta,
Kengo Saito, and Hiroshi Shirasawa, and Naohisa Isegawa, and Masashi Shiiba, and Katsuhiro Uzawa, and Hideki Tanzawa
December 2005, Current gene therapy,
Kengo Saito, and Hiroshi Shirasawa, and Naohisa Isegawa, and Masashi Shiiba, and Katsuhiro Uzawa, and Hideki Tanzawa
June 2011, Virology journal,
Kengo Saito, and Hiroshi Shirasawa, and Naohisa Isegawa, and Masashi Shiiba, and Katsuhiro Uzawa, and Hideki Tanzawa
November 2023, Viruses,
Kengo Saito, and Hiroshi Shirasawa, and Naohisa Isegawa, and Masashi Shiiba, and Katsuhiro Uzawa, and Hideki Tanzawa
December 2021, Pharmaceutics,
Kengo Saito, and Hiroshi Shirasawa, and Naohisa Isegawa, and Masashi Shiiba, and Katsuhiro Uzawa, and Hideki Tanzawa
October 2002, The Prostate,
Kengo Saito, and Hiroshi Shirasawa, and Naohisa Isegawa, and Masashi Shiiba, and Katsuhiro Uzawa, and Hideki Tanzawa
July 2012, Expert opinion on biological therapy,
Copied contents to your clipboard!